USTR Extends or Grants China Section 301 Exclusions For Certain COVID-19 Medical Products

Posted on Dec 23

12/23/2020

USTR Extends or Grants China Section 301 Exclusions For Certain COVID-19 Medical Products

The Office of the United States Trade Representative (USTR) announced that it will extend China Section 301 duty exclusions for many products needed to treat Covid-19. Additionally it was announced that 19 other products would be added to the list of exclusions. A complete list of all items covered by this announcement can be found here. These exclusions are available to any products that meet the specified HTS numbers or product descriptions. It is important to note that these exclusions are only valid through March 31, 2020.

Please contact your V. Alexander account team with any questions and follow us on our website www.valexander.com for updates on this and other topics.

SECURITY NOTICE: This web post may include hyperlinks to websites outside of our internal control. All hyperlinks in this web post are believed to be legitimate and provided for your convenience, however, we cannot take any responsibility for the safety of outside links. We recommend caution as with any hyperlinks in any web post, and to hover your mouse over the links before clicking to insure the destination is as expected or to visit the sites by going to the main websites for the agencies we reference in your web browser and search for the sites for the mentioned topics from there.